TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19884549

Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU)
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU) with irinotecan
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Fluorouracil (FU) with oxaliplatin
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: BRAF mutation
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: KRAS/BRAF mutation
Number of subjects: 711
Study: 18326980

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/d)
Number of subjects: 30
Study: 15936419

Group type: EXPERIMENTAL
Intervention: Three rounds of oral visual inspection by trained health workers at 3-year intervals (intervention group)
Number of subjects: 191873

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 191873
Study: 12183788

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg depot dexamethasone combined with 60 mg lidocaine
Number of subjects: 0
Study: 10332595

Group type: EXPERIMENTAL
Intervention: T1-weighted GRE sequence
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional spin echo (CSE)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Half-Fourier spin echo (HFSE)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Gradient recalled echo (GRE)
Number of subjects: 3
Study: 8758853

Group type: EXPERIMENTAL
Intervention: Oral administration of 'Nao An' capsules
Number of subjects: 4793
Study: 1745034

Group type: EXPERIMENTAL
Intervention: EOPROTIN
Number of subjects: 28

Group type: COMPARATOR
Intervention: Human albumin
Number of subjects: 28
Study: 6357037

Group type: EXPERIMENTAL
Intervention: Systemic antibiotics
Number of subjects: 200

Group type: COMPARATOR
Intervention: No antibiotics (Control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Wound infection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Avoiding antibiotic prophylaxis
Number of subjects: 200
Study: 29543123

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Self‐administered Foam Rolling (SAFR)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 23
Study: 28089316

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 1376

Group type: EXPERIMENTAL
Intervention: Beta-blockers (time-dependent variable)
Number of subjects: 1376
Study: 26102300

Group type: EXPERIMENTAL
Intervention: HPMC containing ocular lubricants
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Carbomer containing ocular lubricants
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Combination of HPMC and povidone
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Povidone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 49
Study: 24408214

Group type: EXPERIMENTAL
Intervention: High-dose (35 mg) nicotine patch
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 21944677

Group type: EXPERIMENTAL
Intervention: Qualitative ECG analysis
Number of subjects: 5420

Group type: EXPERIMENTAL
Intervention: Quantitative ECG analysis
Number of subjects: 5420
Study: 19200452

Group type: EXPERIMENTAL
Intervention: Single high-dose regimen (1 x 12 microg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard regimen (2 doses of 6 microg with a 28-day interval)
Number of subjects: 0
Study: 17971615

Group type: EXPERIMENTAL
Intervention: Computerized Dynamic Posturography (CDP) therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard Physical Therapy (PT)
Number of subjects: 15
Study: 15114200

Group type: EXPERIMENTAL
Intervention: Circulating-water garment
Number of subjects: 9

Group type: COMPARATOR
Intervention: Forced-air warming
Number of subjects: 9
Study: 11209831

Group type: EXPERIMENTAL
Intervention: Self-assessed duration of exposure using diary method
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Self-assessed duration of exposure using interview method
Number of subjects: 10

Group type: COMPARATOR
Intervention: Measured total daily exposure time
Number of subjects: 10
Study: 9743393

Group type: EXPERIMENTAL
Intervention: Epidural morphine-bupivacaine (0.05 mg/kg epidural morphine and 5 ml 0.25% bupivacaine followed by an infusion of 0.125% bupivacaine with 0.1% morphine)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous PCA morphine sulfate (0.1 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epidural morphine-bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous PCA morphine sulfate
Number of subjects: 40
Study: 7803223

Group type: EXPERIMENTAL
Intervention: Ultraviolet A (UVA) phototherapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Trimethylpsoralen UVA (PUVA) photochemotherapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 3053788

Group type: COMPARATOR
Intervention: Root scaling and planing with removal of all cementum in control quadrants
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Polishing of root surfaces without cementum removal in test quadrants
Number of subjects: 11
Study: 30257983

Group type: EXPERIMENTAL
Intervention: Total Diet Replacement (TDR) programme
Number of subjects: 278

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 278
Study: 28578639

Group type: EXPERIMENTAL
Intervention: ADT plus abiraterone acetate (1000 mg daily) and prednisolone (5 mg daily)
Number of subjects: 1917

Group type: COMPARATOR
Intervention: ADT alone
Number of subjects: 1917
Study: 26632686

Group type: EXPERIMENTAL
Intervention: Subscapularis transthoracic approach (Group A, n = 21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Posterolateral approach (Group B, n = 22)
Number of subjects: 43
Study: 23967796

Group type: EXPERIMENTAL
Intervention: VELscope® (autofluorescence visualization device)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional white-light examination
Number of subjects: 120
Study: 21030491

Group type: COMPARATOR
Intervention: TBNA without ROSE
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: TBNA with ROSE
Number of subjects: 168
Study: 18283250

Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 25
Study: 17201848

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation
Number of subjects: 135

Group type: COMPARATOR
Intervention: High BNP concentration (>18.4 pg/mL)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Plasma BNP concentration
Number of subjects: 135
Study: 14583182

Group type: EXPERIMENTAL
Intervention: 60 type II DM patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30 normal controls
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 24 patients with abnormal myocardial perfusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: 36 patients with normal myocardial perfusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 28 patients with more cardiovascular risk factors
Number of subjects: 60

Group type: COMPARATOR
Intervention: 22 patients with less cardiovascular risk factors
Number of subjects: 60
Study: 10573332

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) beverage
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA) beverage
Number of subjects: 8
Study: 8759075

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 to 90 mg TID)
Number of subjects: 186
Study: 1890860

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 6750282

Group type: EXPERIMENTAL
Intervention: Tolmetin (1,200 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Paracetamol (2,000 mg/day)
Number of subjects: 12
Study: 31936767

Group type: EXPERIMENTAL
Intervention: School-based nutrition education and physical activity intervention (8 months)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (waitlisted)
Number of subjects: 171
Study: 29509640

Group type: EXPERIMENTAL
Intervention: High amount high intensity exercise
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: High amount low intensity exercise
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Low amount low intensity exercise
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Exercise group (combined)
Number of subjects: 216
Study: 28190762

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (5 × 5 Gy) with surgery within 1 week
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy with delay (5 × 5 Gy) with surgery after 4-8 weeks
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Long-course radiotherapy with delay (25 × 2 Gy) with surgery after 4-8 weeks
Number of subjects: 840

Group type: COMPARATOR
Intervention: Short-course radiotherapy with delay
Number of subjects: 840

Group type: COMPARATOR
Intervention: Short-course radiotherapy
Number of subjects: 840

Group type: COMPARATOR
Intervention: Long-course radiotherapy with delay
Number of subjects: 840

Group type: COMPARATOR
Intervention: Short-course radiotherapy with delay vs short-course radiotherapy
Number of subjects: 840
Study: 26208329

Group type: EXPERIMENTAL
Intervention: ICD implantation without any defibrillation threshold (DFT) testing
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Modified 'upper limit of vulnerability (ULV) testing'
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Traditional safety margin testing including ventricular arrhythmia induction
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group (ICD implantation without DFT testing)
Number of subjects: 194
Study: 24114668

Group type: COMPARATOR
Intervention: Continuous erlotinib (100 mg daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intermittent erlotinib (150 mg on alternate days from day 2 to 14, then 150 mg daily on days 15 to 21)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous erlotinib
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intermittent erlotinib
Number of subjects: 60
Study: 22120894

Group type: EXPERIMENTAL
Intervention: 90 mg ginkgo extract tablets, three times daily for 30 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 32
Study: 18369175

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Aspirin and extended-release dipyridamole
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Cilostazole
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel combined
Number of subjects: 20000
Study: 16938913

Group type: EXPERIMENTAL
Intervention: Transcendental meditation program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maharishi Consciousness-Based Health Care
Number of subjects: 0
Study: 14551376

Group type: EXPERIMENTAL
Intervention: Vitamin E (800 IU)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 8
Study: 10857524

Group type: EXPERIMENTAL
Intervention: Aquatic exercise intervention (6-week program)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 9167505

Group type: EXPERIMENTAL
Intervention: Sertindole 12 mg/day
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Sertindole 20 mg/day
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Sertindole 24 mg/day
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Haloperidol 4 mg/day
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Haloperidol 8 mg/day
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Haloperidol 16 mg/day
Number of subjects: 497

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 497
Study: 7681897

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dihydralazine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prazosin (6 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dobutamine (2.5, 5.0, and 10.0 micrograms/kg/min)
Number of subjects: 24
Study: 3511104

Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Metronidazole (2 g single dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 18
Study: 30893353

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Detached Mindfulness (DM)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 43
Study: 29907818

Group type: EXPERIMENTAL
Intervention: Speckle tracking echocardiography (STE) during semisupine cycle ergometric stress echocardiography
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Speckle tracking echocardiography (STE)
Number of subjects: 127
Study: 26197260

Group type: EXPERIMENTAL
Intervention: Educational handout
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study: 23807186

Group type: EXPERIMENTAL
Intervention: Cataract surgery plus intraoperative ranibizumab injection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham group (cataract surgery only)
Number of subjects: 80
Study: 23318050

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 12 weeks, 3 times a week
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (C) for 12 weeks, no training
Number of subjects: 36
Study: 21161480

Group type: EXPERIMENTAL
Intervention: Dortmund Developmental Screening for Preschools (DESK 3-6)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: KiK training for preschool teachers
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: KiK training
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: DESK and training
Number of subjects: 71
Study: 18753745

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Total WMH volume
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Subcortical WMH volume
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Periventricular WMH volume
Number of subjects: 439
Study: 17081355

Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of autologous bone marrow mononuclear cells (BM‐MNCs)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Sodium chloride concluding heparin (control)
Number of subjects: 184
Study: 14692654

Group type: EXPERIMENTAL
Intervention: TOR60 (60 mg daily)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: TOR200 (200 mg daily)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: TAM20 (20 mg daily)
Number of subjects: 648
Study: 11013867

Group type: EXPERIMENTAL
Intervention: Smoking group (mean cotinine concentration 1039 +/- 560 mg/L in serum)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-smoking group (mean cotinine concentration not specified)
Number of subjects: 75
Study: 8775368

Group type: EXPERIMENTAL
Intervention: Tendinitis group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Focal dystonia group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy adult control group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy musician control group
Number of subjects: 60
Study: 1321654

Group type: EXPERIMENTAL
Intervention: Granisetron (160 micrograms kg‐1 body weight)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Haloperidol (3 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Granisetron and Haloperidol (combined)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 4028282

Group type: COMPARATOR
Intervention: Tinidazole 2 g daily taken orally in two separate doses for two consecutive days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ornidazole with the same regimen
Number of subjects: 60
Study: 30923164

Group type: EXPERIMENTAL
Intervention: Early intervention model of care (bedside management within 24 h of admission)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Usual care (referral‐based consultation service)
Number of subjects: 1002
Study: 29495655

Group type: EXPERIMENTAL
Intervention: Mechanical interdental device combined with manual toothbrush
Number of subjects: 22

Group type: COMPARATOR
Intervention: Manual brushing alone (Control)
Number of subjects: 22
Study: 27468840

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) at 50 mA
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) at 40 mA
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 13
Study: 24616359

Group type: EXPERIMENTAL
Intervention: Broad public release consent
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Data sharing preferences
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Data sharing concerns
Number of subjects: 113
Study: 21311362

Group type: EXPERIMENTAL
Intervention: Whole body (WB) precooling
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whole body (WB) and head + hand (HH) cooling
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whole body (WB) cooling
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 10
Study: 15954914

Group type: EXPERIMENTAL
Intervention: EPO administration (50 units per kg once per week) in group II
Number of subjects: 36

Group type: COMPARATOR
Intervention: No EPO treatment in group III
Number of subjects: 36

Group type: COMPARATOR
Intervention: CKD stage 1 to 2 (group I)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Healthy volunteers (controls)
Number of subjects: 36
Study: 11931316

Group type: EXPERIMENTAL
Intervention: Perturbation conditions (randomly altered amplitudes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No-perturbation conditions (equal-amplitude tones)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall analysis of across-frequency correlation functions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual data analysis
Number of subjects: 0
Study: 9755272

Group type: EXPERIMENTAL
Intervention: Ketamine/Midazolam (K/M)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Fentanyl/Midazolam (F/M)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 260
Study: 8046602

Group type: EXPERIMENTAL
Intervention: Regular release formulation of tiaprofenic acid (300 mg)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Sustained release (SR) formulation of tiaprofenic acid (300 mg)
Number of subjects: 4
Study: 3186477

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking (NNS) by pacifier for 5 minutes
Number of subjects: 24

Group type: COMPARATOR
Intervention: No pacifier (Control)
Number of subjects: 24
Study: 5309493

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 14000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14000
Study: 11602855

Group type: EXPERIMENTAL
Intervention: Celsior solution
Number of subjects: 100

Group type: COMPARATOR
Intervention: University of Wisconsin (U.W.) solution
Number of subjects: 100
Study: 31342893

Group type: EXPERIMENTAL
Intervention: School-based intervention program encouraging healthy eating habits and physical activity.
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Combined school and home-based intervention for overweight or obese adolescents.
Number of subjects: 97
Study: 29982083

Group type: EXPERIMENTAL
Intervention: High self-efficacy (HSE) induction
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 34
Study: 27235377

Group type: EXPERIMENTAL
Intervention: Individualized counseling on using the surrounding built environment to increase MVPA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-of-care lifestyle modification counseling (Control)
Number of subjects: 60
Study: 24394747

Group type: EXPERIMENTAL
Intervention: Buprenorphine Transdermal Delivery System (BTDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22017520

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg/day
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 20537751

Group type: EXPERIMENTAL
Intervention: Euglycaemia during moderate aerobic exercise
Number of subjects: 7

Group type: COMPARATOR
Intervention: Hyperglycaemia during moderate aerobic exercise
Number of subjects: 7
Study: 17652730

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Other antiepileptic drugs
Number of subjects: 73

Group type: COMPARATOR
Intervention: Normally developing children
Number of subjects: 73
Study: 16325366

Group type: EXPERIMENTAL
Intervention: Dexrazoxane supplementation (400 mg/m²) after epirubicin infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epirubicin-based chemotherapy without dexrazoxane
Number of subjects: 20
Study: 11990278

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.5 microg kg(‐1) over 30 s, followed by an infusion of 0.1 microg kg min(‐1) (group R)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 microg kg(‐1) over 30 s, followed by an infusion of saline (group A)
Number of subjects: 40
Study: 10710173

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (0.325 mg/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (0.650 mg/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (0.325 mg/kg) and (0.650 mg/kg)
Number of subjects: 8
Study: 7815715

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin 50 mg plus epidural 0.1 mg buprenorphine in 8 ml of 0.25% bupivacaine and 15 micrograms buprenorphine in 1 ml of 0.25% bupivacaine at 1 ml.h‐1 for 48 h
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural 0.1 mg buprenorphine in 8 ml of 0.25% bupivacaine and 15 micrograms buprenorphine in 1 ml of 0.25% bupivacaine at 1 ml.h‐1 for 48 h
Number of subjects: 40
Study: 2765342

Group type: EXPERIMENTAL
Intervention: Self-tuning, closed-loop controller regulating isoflurane concentration
Number of subjects: 33

Group type: COMPARATOR
Intervention: Manual control of arterial pressure
Number of subjects: 33